(S)-benzyl 1-(5-(4-(4-methoxyphenethoxy)benzyl)-1,2,4-oxadiazol-3-yl)-6-amino-1-oxohexan-2-ylcarbamate

ID: ALA212095

Chembl Id: CHEMBL212095

PubChem CID: 44414103

Max Phase: Preclinical

Molecular Formula: C32H36N4O6

Molecular Weight: 572.66

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COc1ccc(CCOc2ccc(Cc3nc(C(=O)[C@H](CCCCN)NC(=O)OCc4ccccc4)no3)cc2)cc1

Standard InChI:  InChI=1S/C32H36N4O6/c1-39-26-14-10-23(11-15-26)18-20-40-27-16-12-24(13-17-27)21-29-35-31(36-42-29)30(37)28(9-5-6-19-33)34-32(38)41-22-25-7-3-2-4-8-25/h2-4,7-8,10-17,28H,5-6,9,18-22,33H2,1H3,(H,34,38)/t28-/m0/s1

Standard InChI Key:  HURJRTPBYBBBCS-NDEPHWFRSA-N

Alternative Forms

1. Parent:

   

   ALA212095

   benzyl N-[(2S)-6-amino-1-[5-[[4-[2-(4-methoxyphenyl)ethoxy]phenyl]methyl]-1,2,4-oxadiazol-3-yl]-1-oxohexan-2-yl]carbamate

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 572.66

Molecular Weight (Monoisotopic): 572.2635

AlogP: 4.90

#Rotatable Bonds: 16

Polar Surface Area: 138.80

Molecular Species: BASE

HBA: 9

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 12.93

CX Basic pKa: 10.00

CX LogP: 5.23

CX LogD: 2.72

Aromatic Rings: 4

Heavy Atoms: 42

QED Weighted: 0.14

Np Likeness Score: -0.47

References

1. Sperandio D, Tai VW, Lohman J, Hirschbein B, Mendonca R, Lee CS, Spencer JR, Janc J, Nguyen M, Beltman J, Sprengeler P, Scheerens H, Lin T, Liu L, Gadre A, Kellogg A, Green MJ, McGrath ME..  (2006)  Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitors.,  16  (15): [PMID:16725321] [10.1016/j.bmcl.2006.04.088]

Source

Source(1):

• Scientific Literature